NCT02700776View on ClinicalTrials.gov

1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer

TerminatedOBSERVATIONAL
Enrollment

417

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

February 27, 2017

Study Completion Date

February 27, 2017

Conditions
Healthy Volunteers
Interventions
OTHER

Phlebotomy - Blood sampling for GP88 at MM

Women undergoing a screening mammogram will have a blood sample drawn to look for GP88.

PROCEDURE

SOC Tissue biopsy

standard of care tissue biopsy if clinically indicated.

Trial Locations (2)

21061

Baltimore Washington Medical Center, Glen Burnie

21201

University of Maryland, Greenebaum Cancer Center, Baltimore

Sponsors

Collaborators (1)

A&G Pharmaceutical
All Listed Sponsors
collaborator

A&G Pharmaceutical

INDUSTRY

lead

University of Maryland, Baltimore

OTHER

NCT02700776 - 1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer | Biotech Hunter | Biotech Hunter